Skip to main content
. 2017 Jan 15;9(1):42–49. doi: 10.4251/wjgo.v9.i1.42

Table 1.

Baseline characteristics of all patients in the series and comparison of the groups with lower (≤ 300 × 109/ L) and higher (> 300 × 109/ L) platelet counts n (%)

Total (%) (n = 51) 300 (n = 26) > 300 (n = 25) χ2
Age (yr)
> 60 21 (41.2) 10 (38.5) 11 ( 44.0) P = 0.69
≤ 60 30 (58.8) 16 (61.5) 14 (56.0)
Clinical stage
II 25 (49.0) 15 (57.7) 10 (40.0) P = 0.21
III 26 (51.0) 11 (42.3) 15 (60.0)
CEA (n = 50)
> 5 25 (50.0) 11 (44.0) 14 (56.0) P = 0.4
< 5 25 (50.0) 14 (56.0) 11 (44.0)
Symptoms
Obstruction/pain 13 (25.5) 6 (23.1) 7 (28.0) P = 0.69
Bleeding/ asymptomatic 38 (74.5) 20 (76.9) 18 (72.0)
Type of surgery
Anterior resection 27 (52.9) 13 (50.0) 14 (56.0) Anterior resection vs
APR 19 (37.3) 11 (42.3) 8 (32.0) APR/exenteration
Pelvic/exenteration 2 (3.9) 0 2 (8.0) P = 0.77
None 3 (5.9) 2 (7.7) 1 (4.0)
Pathologic response
No response 15 (29.4) 8 (30.8) 7 (28.0) No/minimal/
Minimal 7 (13.7) 4 (15.3) 3 (12.0) Moderate resp vs
Moderate 15 (29.4) 3 (11.6) 12 (48.0) Good/complete
Good 5 (9.8) 5 (19.2) 0 P = 0.015
Complete 9 (17.6) 6 (23.1) 3 (12.0)
Lymph nodes at surgery
Negative 31 (60.8) 15 (57.7) 16 (64.0) P = 0.61
Positive 16 (31.4) 9 (34.6) 7 (28.0)
No surgery 3 (5.9) 2 (7.7) 1 (4.0)

Pre-operative CEA not available in one patient. Lymph node evaluation was not available in the pathology report in one patient. APR: Abdomino-perineal resection; CEA: Carcinoembryonic antigen.